Annual CFO
-$41.29 M
-$14.64 M-54.94%
March 31, 2024
Summary
- As of February 26, 2025, LSB annual cash flow from operations is -$41.29 million, with the most recent change of -$14.64 million (-54.94%) on March 31, 2024.
- During the last 3 years, LSB annual CFO has fallen by -$4.90 million (-13.45%).
- LSB annual CFO is now -54.94% below its all-time high of -$26.65 million, reached on March 31, 2023.
Performance
LSB Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
N/A
September 1, 2024
Summary
- LSB quarterly cash flow from operations is not available.
Performance
LSB Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
N/A
September 1, 2024
Summary
- LSB TTM cash flow from operations is not available.
Performance
LSB TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
LSB Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -54.9% | - | - |
| 3 y3 years | -13.4% | - | - |
| 5 y5 years | -13.4% | - | - |
LSB Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -54.9% | at low | ||||
| 5 y | 5-year | -54.9% | at low | ||||
| alltime | all time | -54.9% | at low |
LakeShore Biopharma Co Ltd Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | -$41.29 M(+54.9%) | - | - |
| Sep 2023 | - | -$20.15 M(+28.5%) | -$20.15 M(+28.5%) |
| Mar 2023 | -$26.65 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$15.68 M | -$15.68 M |
| Mar 2022 | -$27.02 M(-25.8%) | - | - |
| Mar 2021 | -$36.40 M | - | - |
FAQ
- What is LakeShore Biopharma Co Ltd annual cash flow from operations?
- What is the all time high annual CFO for LakeShore Biopharma Co Ltd?
- What is LakeShore Biopharma Co Ltd annual CFO year-on-year change?
- What is the all time high quarterly CFO for LakeShore Biopharma Co Ltd?
- What is the all time high TTM CFO for LakeShore Biopharma Co Ltd?
What is LakeShore Biopharma Co Ltd annual cash flow from operations?
The current annual CFO of LSB is -$41.29 M
What is the all time high annual CFO for LakeShore Biopharma Co Ltd?
LakeShore Biopharma Co Ltd all-time high annual cash flow from operations is -$26.65 M
What is LakeShore Biopharma Co Ltd annual CFO year-on-year change?
Over the past year, LSB annual cash flow from operations has changed by -$14.64 M (-54.94%)
What is the all time high quarterly CFO for LakeShore Biopharma Co Ltd?
LakeShore Biopharma Co Ltd all-time high quarterly cash flow from operations is -$15.68 M
What is the all time high TTM CFO for LakeShore Biopharma Co Ltd?
LakeShore Biopharma Co Ltd all-time high TTM cash flow from operations is -$15.68 M